A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer

Trial Profile

A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Gentamicin (Primary) ; Levofloxacin
  • Indications Bacterial infections; Diabetic foot ulcer; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Acronyms COACT-1
  • Sponsors Innocoll
  • Most Recent Events

    • 03 Nov 2016 Results published in Innocoll Holdings plc media release.
    • 03 Nov 2016 Primary endpoint has not been met. (Clinical Cure (Resolution of all clinical signs and symptoms of infection)), as per Innocoll Holdings plc media release.
    • 07 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Aug 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top